View Older Stories View More Recent Stories

May 14, 2020 04:05PM Motus GI Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 5, 2020 08:00AM Motus GI Expands Intellectual Property Portfolio with U.S. Patent for the Pure-Vu® System’s Sensing Technology and Suction Control
May 4, 2020 06:04PM Motus GI to Release First Quarter 2020 Results and Provide a Business Update on May 14th
Apr 7, 2020 09:00AM Motus GI Receives Approval from the Israeli Ministry of Health to Initiate Commercial Sales of its GEN2 Pure-Vu® System in Israel
Mar 30, 2020 04:05PM Motus GI Reports Fourth Quarter and Year End 2019 Financial Results and Provides Corporate Update
Mar 27, 2020 09:13AM Motus GI Holdings (MOTS) Receives CE Mark Approval for GEN2 Pure-Vu System
Mar 27, 2020 09:12AM Motus GI Receives CE Mark Approval for GEN2 Pure-Vu System
Mar 12, 2020 08:00AM Motus GI Moving Corporate Headquarters to Greater Boston Area to Foster Closer Collaboration and Drive Operational Efficiency
Mar 4, 2020 08:00AM Motus GI to Release Fourth Quarter 2019 Results and Provide a Business Update on March 30th
Feb 13, 2020 08:00AM Motus GI to Participate in Life Science Intelligence Emerging Medtech Summit 2020
Dec 18, 2019 08:00AM Motus GI Announces $8.0 Million Secured Term Loan from Silicon Valley Bank
Dec 16, 2019 08:00AM Motus GI to Participate in the New York Society for Gastrointestinal Endoscopy 43rd Annual New York Course
Nov 26, 2019 04:05PM Motus GI to Present at the Piper Jaffray 31st Annual Healthcare Conference
Nov 14, 2019 07:00AM Motus GI Reports Third Quarter 2019 Financial Results and Provides Corporate Update
Nov 11, 2019 08:00AM Motus GI Announces EXPEDITE Study Initiated by Boston Medical Center to Evaluate Clinical Effectiveness of Pure-Vu® System for Improving Bowel Preparation Rates
Nov 1, 2019 08:00AM Motus GI to Release Third Quarter 2019 Results on Thursday, November 14, 2019
Oct 7, 2019 09:00AM Motus GI Announces First Commercial Placements of Pure-Vu® System as part of U.S. Market Launch
Sep 19, 2019 08:00AM Motus GI to Present at the Ladenburg Thalmann Healthcare Conference
Aug 9, 2019 07:05AM Motus GI Reports Second Quarter 2019 Financial Results and Provides Corporate Update
Jul 25, 2019 08:10AM Motus GI Holdings (MOTS) Reports Issuance of New European Patent for the Pure-Vu System
Jul 25, 2019 08:00AM Motus GI Announces Issuance of New European Patent for the Pure-Vu® System
Jun 19, 2019 08:05AM Motus GI Bolsters Commercial and Quality/Regulatory Expertise with Two Key Senior Management Additions
Jun 18, 2019 08:05AM Motus GI to Present at the JMP Securities Life Sciences Conference
Jun 11, 2019 07:31AM Motus GI Holdings (MOTS) Granted FDA Clearance to Market Pure-Vu GEN2
Jun 11, 2019 07:30AM Motus GI Receives FDA Clearance to Market Pure-Vu® GEN2
May 20, 2019 12:34PM Motus GI Holdings (MOTS) Highlights Positive Clinical Results from REDUCE Study Evaluating Pure-Vu System in Hospitalized Colonoscopy Patients
May 20, 2019 12:30PM Motus GI Presents Positive Clinical Results from REDUCE Study Evaluating Pure-Vu® System in Hospitalized Colonoscopy Patients at Digestive Disease Week® 2019
May 15, 2019 08:35AM Motus GI to Present at the 20th Annual B. Riley FBR Investor Conference
May 10, 2019 08:00AM Motus GI Reports First Quarter 2019 Financial Results and Provides Corporate Update
Apr 29, 2019 08:05AM Motus GI to Present Clinical Results from REDUCE Study Evaluating the Pure-Vu® System at Digestive Disease Week® 2019
Mar 27, 2019 06:35AM Motus GI Reports Full Year 2018 Financial Results and Provides Business Outlook
Mar 18, 2019 08:05AM Motus GI Expands Intellectual Property Portfolio with Issuance of New U.S. Patent for the Pure-Vu® System
Mar 13, 2019 08:35AM Motus GI to Present at the Oppenheimer 29th Annual Healthcare Conference
Feb 19, 2019 08:15AM Motus GI Holdings (MOTS) Announces Publication of Pure-Vu System Clinical Study Data in Peer-Reviewed Journal of Clinical Gastroenterology
Feb 19, 2019 08:05AM Motus GI Announces Publication of Pure-Vu® System Clinical Study Data in Peer-Reviewed Journal of Clinical Gastroenterology
Jan 3, 2019 08:37AM Motus GI Holdings (MOTS) Reports Publication of Pure-Vu System Clinical Study Data in Peer-Reviewed Endoscopy Journal
Jan 3, 2019 08:30AM Motus GI Announces Publication of Pure-Vu® System Clinical Study Data in Peer-Reviewed Endoscopy Journal
Jan 2, 2019 08:30AM Motus GI to Present at Biotech Showcase™ 2019
Nov 20, 2018 08:00AM Motus GI to Present at the Piper Jaffray Healthcare Conference
Nov 14, 2018 07:35AM Motus GI Reports 2018 Third Quarter Financial Results and Provides Business Update
Nov 8, 2018 08:00AM Motus GI Announces Successful Clinical Use of Pure-Vu® Slim Sleeve with Slim Colonoscopes
Oct 10, 2018 08:05AM Motus GI Presents Positive Clinical Data from U.S. Prospective Study of the Pure-Vu® System at the 2018 American College of Gastroenterology (ACG) Annual Meeting
Oct 1, 2018 08:05AM Motus GI to Present at the Ladenburg Thalmann 2018 Healthcare Conference
Sep 25, 2018 07:00AM Motus GI Appoints Medical Device Commercial Leader Timothy P. Moran as Chief Executive Officer; Mark Pomeranz Continues in Key Executive Leadership Role as President and Chief Operating Officer
Sep 13, 2018 08:00AM Motus GI Receives FDA Clearance to Market Pure-Vu® Slim Sleeve for Use with Slim Colonoscopes
Aug 14, 2018 08:05AM Motus GI Reports 2018 Second Quarter Financial Results and Provides Business Update
Aug 9, 2018 08:35AM Motus GI Appoints Jeff Hutchison as VP of U.S. Sales and Commercial Operations
Jul 30, 2018 08:05AM Motus GI Strengthens IP Portfolio with Issuance of Japanese Patent for the Pure-Vu® System
Jun 25, 2018 07:05AM Motus GI Announces Inclusion in the Russell Microcap® Index
Jun 4, 2018 07:41AM Motus GI Holdings (MOTS) Highlights Cost-Minimization Data on Pure-Vu System
View More Recent Stories View Older Stories